Sims Karen sold ABUS
February 2, 2024 · Form 4 insider transaction
Sims Karen sold 4,358 shares of Arbutus Biopharma Corporation at $2.31 per share, a transaction worth $10.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,358
Price
$2.31
Total value
$10.1K
InsiderSims Karen
Role—
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2024
Filing dateFebruary 5, 2024
Shares owned after125,542
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 9, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units.